Vikram V. Bhise, MD

Dr. Vikram Bhise, MD, is Professor of Pediatrics and Neurology at Rutgers Robert Wood Johnson Medical School and serves as Division Chief of Child Neurology and Neurodevelopmental Disabilities. He received his BA from Drew University and his MD from UMDNJ–Robert Wood Johnson Medical School, followed by residency training in Pediatrics at Maimonides Medical Center. He completed fellowships in Child Neurology at Montefiore Medical Center, Clinical Neurophysiology at SUNY Downstate, and Neuroimmunology at SUNY Stony Brook. Dr. Bhise’s clinical and academic work focuses on pediatric neurological disorders, particularly multiple sclerosis, epilepsy, and other neuroimmunologic diseases. He has received research funding from the National Multiple Sclerosis Society and other foundations and has contributed extensively to the literature on pediatric MS, epilepsy, and neuroimmunology.

Pediatric multiple sclerosis; Neuroimmunology; Epilepsy; Rare diseases; Clinical neurophysiology

Summary:
Dr. Bhise’s research centers on pediatric neuroimmunologic disorders, with a particular focus on multiple sclerosis and related demyelinating diseases. His work integrates clinical research with emerging bioinformatics and AI/ML approaches, including the use of multi-omics data to improve diagnosis, prognostication, and personalized treatment strategies in rare neurological diseases.

The Bhise research program focuses on improving the diagnosis and management of pediatric neuroimmunologic disorders, particularly multiple sclerosis. His work spans clinical, translational, and computational domains, including studies of disease mechanisms, biomarkers, and therapeutic outcomes. Current recent efforts include the examination of markers for individuals with radiological findings of multiple sclerosis (MS) of children to accelerate diagnosis and enable precision care for patients with rare neurological diseases. Additional areas of investigation include quality of life in pediatric MS, cognitive remediation strategies, and the epidemiology of neurological complications such as epilepsy and sleep disorders in children. He collaborates across institutions and disciplines to translate data-driven insights into clinically actionable tools.

• Singh K, Usman S, Zeeshan S, Yanamala N, Nichols M, Bhise V, et al.
  Bioinformatics and AI/ML approaches using multi-omics data to accelerate diagnosis and delivery of precision care for patients with rare diseases.
  Methods in Cell Biology. 2026;204:109–139.
• Henderson M, Horton DB, Bhise V, et al.
  Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001–2020.
  JAMA Neurology. 2023;80(8):860–867.
• Bhise V, Waltz M, Casper TC, et al.
  Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort.
  Multiple Sclerosis and Related Disorders. 2023;71.
• Veras J, Thoby E, Nallapati S, Jimenez M, Bhise V.
  Transition Readiness and Quality of Life in Pediatric Multiple Sclerosis.
  Child: Care, Health and Development. 2024;50:e13304.
• Flannery KP, Safwat S, Matsell E, et al., Bhise V.
  ATP8A2-related disorders: A novel missense variant and phenotypic variability.
  Neurogenetics. 2024;25(4):425–433.